Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Novartis’ Promacta approved by FDA for first-line treatment of severe aplastic anemia The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Novartis’ Promacta (eltrombopag), approving it… bypharmanewsdailyNovember 19, 2018
